Literature DB >> 16629373

Hepatoprotective activity of Psidium guajava Linn. leaf extract.

Chanchal K Roy1, Jagadish V Kamath, Mohammed Asad.   

Abstract

The study was designed to evaluate the hepatoprotective activity of P. guajava in acute experimental liver injury induced by carbon tetrachloride, paracetamol or thioacetamide and chronic liver damage induced by carbon tetrachloride. The effects observed were compared with a known hepatoprotective agent, silymarin. In the acute liver damage induced by different hepatotoxins, P. guajava leaf extracts (250 and 500mg/kg, po) significantly reduced the elevated serum levels of aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase and bilirubin. The higher dose of the extract (500 mg/kg, po) prevented the increase in liver weight when compared to hepatoxin treated control, while the lower dose was ineffective except in the paracetamol induced liver damage. In the chronic liver injury induced by carbon tetrachloride, the higher dose (500 mg/kg, po) of P. guajava leaf extract was found to be more effective than the lower dose (250 mg/kg, po). Histological examination of the liver tissues supported the hepatoprotection. It is concluded that the aqueous extract of leaves of guava plant possesses good hepatoprotective activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16629373

Source DB:  PubMed          Journal:  Indian J Exp Biol        ISSN: 0019-5189            Impact factor:   0.818


  12 in total

1.  Psidium guajava Leaf Extracts and Their Quercetin Protect HepG2 Cell Lines Against CCL4 Induced Cytotoxicity.

Authors:  K Vijayakumar; R L Rengarajan; R Radhakrishnan; Shilu Mathew; Ishtiaq Qadri; A Vijaya Anand
Journal:  Indian J Clin Biochem       Date:  2018-04-11

2.  Guava leaves extract ameliorates STZ induced diabetes mellitus via activation of PI3K/AKT signaling in skeletal muscle of rats.

Authors:  Muthukumaran Jayachandran; Ramachandran Vinayagam; Baojun Xu
Journal:  Mol Biol Rep       Date:  2020-04-02       Impact factor: 2.316

3.  Phytochemical investigation and antimicrobial activity of Psidium guajava L. leaves.

Authors:  A M Metwally; A A Omar; F M Harraz; S M El Sohafy
Journal:  Pharmacogn Mag       Date:  2010-07       Impact factor: 1.085

4.  Hepatoprotective activity of Hepax-a polyherbal formulation.

Authors:  V C Devaraj; B Gopala Krishna; G L Viswanatha; Jagadish V Kamath; Sanjay Kumar
Journal:  Asian Pac J Trop Biomed       Date:  2011-04

5.  In vitro antimicrobial activity of methanolic leaf extract of Psidium guajava L.

Authors:  Anju Dhiman; Arun Nanda; Sayeed Ahmad; B Narasimhan
Journal:  J Pharm Bioallied Sci       Date:  2011-04

6.  Protective effects of curcumin and vitamin E on carbon tetrachloride-induced nephrotoxicity in rats.

Authors:  G Venkatanarayana; G Sudhakara; P Sivajyothi; Pala Indira
Journal:  EXCLI J       Date:  2012-09-14       Impact factor: 4.068

7.  Redox Control of Antioxidant and Antihepatotoxic Activities of Cassia surattensis Seed Extract against Paracetamol Intoxication in Mice: In Vitro and In Vivo Studies of Herbal Green Antioxidant.

Authors:  U Seeta Uthaya Kumar; Yeng Chen; Jagat R Kanwar; Sreenivasan Sasidharan
Journal:  Oxid Med Cell Longev       Date:  2016-12-08       Impact factor: 6.543

Review 8.  Health Effects of Psidium guajava L. Leaves: An Overview of the Last Decade.

Authors:  Elixabet Díaz-de-Cerio; Vito Verardo; Ana María Gómez-Caravaca; Alberto Fernández-Gutiérrez; Antonio Segura-Carretero
Journal:  Int J Mol Sci       Date:  2017-04-24       Impact factor: 5.923

Review 9.  Psidium guajava: A Single Plant for Multiple Health Problems of Rural Indian Population.

Authors:  Poonam G Daswani; Manasi S Gholkar; Tannaz J Birdi
Journal:  Pharmacogn Rev       Date:  2017 Jul-Dec

10.  Evaluation of Acute and Subacute Toxicities of Psidium guajava Methanolic Bark Extract: A Botanical with In Vitro Antiproliferative Potential.

Authors:  Hermione T Manekeng; Armelle T Mbaveng; Samuel A Ntyam Mendo; Armel-Joseph D Agokeng; Victor Kuete
Journal:  Evid Based Complement Alternat Med       Date:  2019-12-11       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.